Peripheral Arterial Disease as an Undertreated Coronary Equivalent: Statin Gaps, Amputation Rates and Referral Failure
DOI:
https://doi.org/10.5281/zenodo.22365946Abstract
Coronary artery disease long ago established a treatment culture built around statins, antiplatelet therapy, structured
cardiac rehabilitation, and rapid specialist referral for escalating symptoms. Peripheral arterial disease shares the
same underlying atherosclerotic process and, as the evidence below sets out, carries at least as much long-term
cardiovascular risk. What it has not shared is the same treatment culture.
References
Subherwal S, Patel MR, Kober L, et al. "Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study". Eur J Prev Cardiol 22(2015):317-325.
[Comparative statin-prescribing figures as summarized in a clinical review of PAD under-recognition, citing 2016 prescribing data across atherosclerotic disease categories]. Clinical Correlations, 2026.
Sutzko DC, Vemulapalli S, et al. "Supervised Exercise Therapy for Symptomatic Peripheral Artery Disease Among Medicare Beneficiaries Between 2017 and 2018: Participation Rates and Outcomes". Circ Cardiovasc Qual Outcomes 14(2021):e007953.
[US nontraumatic lower-extremity amputation incidence and post-amputation mortality, as summarized in a clinical review citing US epidemiologic and Medicare cohort data, 2000-2008]. Clinical Correlations, 2026.
